L
PharmaceuticalsMidcap
Lupin Limited is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world.
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 30.18 | 34.91 |
| PB Ratio | 5.73 | 5.53 |
| Dividend Yield | 0.55% | 0.62% |
Understand what these metrics mean.
For peer comparison & financials,